INO

Inovio Pharmaceuticals, Inc. is a biotechnology company focused on developing and commercializing DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company's proprietary DNA medicines platform uses precisely designed DNA plasmids delivered through electroporation devices to activate immune responses against specific diseases. Inovio's pipeline includes vaccine candidates for human papillomavirus (HPV)-related diseases, various cancers, and infectious diseases including COVID-19 and Lassa fever. The company collaborates with academic institutions, government agencies, and pharmaceutical partners to advance its clinical programs.